Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460843) titled 'Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Single (Outcomes Assessor).

Primary Sponsor: Peking University First Hospital

Condition: Prostate Cancer (Diagnosis)

Intervention: Procedure: TB+PB

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: March 1, 2026

Target Sample Size: 592

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07460843

Disclaimer: Curated by HT Syndication...